March Biosciences, Inc. — Form D
March Biosciences, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-12. The offering totals $9K, of which $9K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-12
- Form: D
- Accession: 0001567619-23-007160
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9K
- Amount sold: $9K
- Minimum investment: $9K
- Investors: 1
- Date of first sale: 2023-09-01
- Revenue range: Decline to Disclose
- SEC file number: 021-491867
Issuer
- Name: March Biosciences, Inc.
- CIK: 0001965802
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 7255 Helix Park, HOUSTON, TX, 77030
- Phone: 713-898-0838
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Thomas Luby | Director | Houston, TX |
| Peter Olagunju | Director | Houston, TX |
| Joseph Petrosino | Director | Houston, TX |
| Sarah Hein | Director | HOUSTON, TX |
| Sarah Hein | Executive Officer | HOUSTON, TX |
| Maksim Mamonkin | Director | Houston, TX |
| Maksim Mamonkin | Executive Officer | Houston, TX |
Other filings by this issuer (1)
More